- Medical School - UT Southwestern Medical School (1989-1993)
- Internship - Children's Health Dallas (1993-1994), Pediatrics
- Residency - Children's Health Dallas (1994-1996), Pediatrics
- Fellowship - Johns Hopkins School of Medicine (1996-1999), Pediatric Hematology/oncology
Daniel Bowers, M.D.
- Pediatrics - Hematology-Oncology
- Pediatric Brain Tumors
Daniel Bowers, M.D., is an Associate Professor in the Department of Pediatrics’ Division of Pediatric Hematology and Oncology at UT Southwestern. He also is Medical Director of Pediatric Neuro-Oncology at Children’s Health, as well as Medical Director of the After the Cancer Experience program for childhood cancer survivors.
After receiving his undergraduate degree from Texas A&M University, Dr. Bowers earned his medical degree at UT Southwestern. He completed his residency in general pediatrics at UT Southwestern and performed his fellowship in pediatric hematology and oncology at the Johns Hopkins University School of Medicine.
Dr. Bowers is a full member of the Children’s Oncology Group and serves on the central nervous system tumors committee, where his role is to develop new treatments for low-grade gliomas in children. He soon will be leading a national clinical trial for children with recurrent low-grade gliomas.
Dr. Bowers is an expert in understanding the long-term side effects seen among childhood brain tumor survivors. He has studied the development of secondary brain tumors after treatment for a primary brain tumor, as well as the risk of stroke after brain tumor treatment.
He was included in D Magazine's Best Doctors list for 2018 and has been named as a favorite oncology professional by CureSearch for Children’s Cancer. He serves on the advisory committee on childhood cancers for the Cancer Prevention and Research Institute of Texas and as a member of the board of directors of the Clayton Dabney Foundation.
He is a member of the American Society of Clinical Oncology, the Society for Neuro-Oncology, the American Society of Pediatric Hematology/Oncology, and the Society for Pediatric Research.
Meet Dr. Bowers
Pediatric Neuro-Oncologist in Dallas
Pediatric neuro-oncologist Daniel Bowers, M.D., cares for children with brain tumors, along with other members of the pediatric brain tumor multidisciplinary team, including pediatric neurosurgeons, radiation oncologists, pediatric neurologists, neuro-radiologists, and neuro-pathologists.
Dr. Bowers designs and implements nonsurgical treatment plans that may include chemotherapy or radiation therapy, and he manages any medical complications that may arise during treatment.
As Medical Director of Pediatric Neuro-Oncology at Children’s Health, Dr. Bowers strongly believes in the care his team provides.
“We offer the most advanced treatment that can be found anywhere in the world for a child with a brain tumor,” he says. “Our outstanding group of doctors is unmatched. You can get it all right here.”
With two children of his own, Dr. Bowers treats patients the way he hopes his kids would be treated if they were going through a similar situation. He seeks to offer hope to families, no matter their situation.
“I’ve learned through experience that just because statistics say that a situation looks bleak, there are exceptions, and there absolutely are reasons to keep trying and seeking out new treatments or trying new things because sometimes they do work, or at least they help, and you can learn from them,” he says.
In addition to his clinical care of children with brain tumors, Dr. Bowers leads the After the Cancer Experience program at Children’s Health, a childhood cancer survivorship program that monitors survivors of childhood cancer for long-term effects they may have from their cancer treatment or the cancer itself.
As more children survive their cancer diagnosis, we know that about two-thirds of them have some long-term complication and about one-third will have what is considered a severe or life-threatening complication.
“When we monitor these children as they grow, we can intervene if something starts to change or go wrong and help them through it,” he says.
Dr. Bowers is well known nationally for his understanding of the long-term side effects seen among childhood brain tumor survivors.
- Society for Pediatric Research (2006)
- American Society of Pediatric Hematology/Oncology (2001)
- Society for Neuro-Oncology (2000)
- American Society of Clinical Oncology (1999)
- Children’s Oncology Group
- Favorite Oncology Professionals 2013-2013, CureSearch for Childrens Cancer
- Elected to the Society for Pediatric Research 2006-2006
- Outstanding Graduate in the College of Science 1989-1989
- Best Pediatric Specialists in Dallas, D Magazine (2003,2004,2007,2011,2013, 2017)
Strokes Among Childhood Brain Tumor Survivors in Goldman S, Turner CD, eds. Late Effects of Treatment for Brain Tumors.
Bowers DC. (2009), Springer; 145-153.
- Strokes Among Childhood Brain Tumor Survivors in Goldman S, Turner CD, eds. Late Effects of Treatment for Brain Tumors.
Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor.
Robinson GW, Kaste SC, Chemaitilly W, Bowers DC, Laughton S, Smith A, Gottardo NG, Partap S, Bendel A, Wright KD, Orr BA, Warner WC, Onar-Thomas A, Gajjar A Oncotarget 2017 Sep 8 41 69295-69302
Comprehensive Analysis of Hypermutation in Human Cancer.
Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, Bowers DC, Laetsch TW, Dunn GP, Johanns TM, Grimmer MR, Smirnov IV, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole KA, Storm PB, Yalon M, Opocher E, Mason G, Thomas GA, Sabel M, George B, Ziegler DS, Lindhorst S, Issai VM, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati MA, Chung J, Ramaswamy V, Irwin MS, Aronson M, Durno C, Taylor MD, Rechavi G, Maris JM, Bouffet E, Hawkins C, Costello JF, Meyn MS, Pursell ZF, Malkin D, Tabori U, Shlien A Cell 2017 Oct
Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
Bowers DC, Moskowitz CS, Chou JF, Mazewski CM, Neglia JP, Armstrong GT, Leisenring WM, Robison LL, Oeffinger KC Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Mar JCO2016701896
Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas.
Drobysheva A, Klesse LJ, Bowers DC, Rajaram V, Rakheja D, Timmons CF, Wang J, Koral K, Gargan L, Ramos E, Park JY Journal of the National Comprehensive Cancer Network : JNCCN 2017 Aug 15 8 978-982
Pediatric low-grade gliomas: implications of the biologic era.
Packer RJ, Pfister S, Bouffet E, Avery R, Bandopadhayay P, Bornhorst M, Bowers DC, Ellison D, Fangusaro J, Foreman N, Fouladi M, Gajjar A, Haas-Kogan D, Hawkins C, Ho CY, Hwang E, Jabado N, Kilburn LB, Lassaletta A, Ligon KL, Massimino M, Meeteren SV, Mueller S, Nicolaides T, Perilongo G, Tabori U, Vezina G, Warren K, Witt O, Zhu Y, Jones DT, Kieran M Neuro-oncology 2016 Sep
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.
Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, Silva A, Boucher K, Henn RE, Kang YJ, Knoff D, Paolella BR, Gladden-Young A, Varlet P, Pages M, Horowitz PM, Federation A, Malkin H, Tracy AA, Seepo S, Ducar M, Van Hummelen P, Santi M, Buccoliero AM, Scagnet M, Bowers DC, Giannini C, Puget S, Hawkins C, Tabori U, Klekner A, Bognar L, Burger PC, Eberhart C, Rodriguez FJ, Hill DA, Mueller S, Haas-Kogan DA, Phillips JJ, Santagata S, Stiles CD, Bradner JE, Jabado N, Goren A, Grill J, Ligon AH, Goumnerova L, Waanders AJ, Storm PB, Kieran MW, Ligon KL, Beroukhim R, Resnick AC Nature genetics 2016 Mar 48 3 273-82
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
Jakacki RI, Foley MA, Horan J, Wang J, Kieran MW, Bowers DC, Bouffet E, Zacharoulis S, Gill SC Journal of neuro-oncology 2016 Jun
Postoperative surveillance of pediatric cerebellar pilocytic astrocytoma.
Alford R, Gargan L, Bowers DC, Klesse LJ, Weprin B, Koral K Journal of neuro-oncology 2016 Aug
Effect of motivation on academic fluency performance in survivors of pediatric medulloblastoma.
Holland AA, Hughes CW, Harder L, Silver C, Bowers DC, Stavinoha PL Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence 2015 Mar 1-17
Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Aug
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.
Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO, Bechet D, Faury D, De Jay N, Ramkissoon LA, Corcoran A, Jones DT, Sturm D, Johann P, Tomita T, Goldman S, Nagib M, Bendel A, Goumnerova L, Bowers DC, Leonard JR, Rubin JB, Alden T, Browd S, Geyer JR, Leary S, Jallo G, Cohen K, Gupta N, Prados MD, Carret AS, Ellezam B, Crevier L, Klekner A, Bognar L, Hauser P, Garami M, Myseros J, Dong Z, Siegel PM, Malkin H, Ligon AH, Albrecht S, Pfister SM, Ligon KL, Majewski J, Jabado N, Kieran MW Nature genetics 2014 May 46 5 462-6
Applicability of apparent diffusion coefficient ratios in preoperative diagnosis of common pediatric cerebellar tumors across two institutions.
Koral K, Alford R, Choudhury N, Mossa-Basha M, Gargan L, Gimi B, Gao A, Zhang S, Bowers DC, Koral KM, Izbudak I Neuroradiology 2014 Jun
Pleomorphic Xanthoastrocytoma of Childhood: MR Imaging and Diffusion MR Imaging Features.
Moore W, Mathis D, Gargan L, Bowers DC, Klesse LJ, Margraf L, Koral K AJNR. American journal of neuroradiology 2014 Jul
Radiation, Atherosclerotic Risk Factors, and Stroke Risk in Survivors of Pediatric Cancer: A Report From the Childhood Cancer Survivor Study.
Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE, Packer RJ, Sklar CA, Bowers DC, Robison LL, Krull KR International journal of radiation oncology, biology, physics 2013 May
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, Macconaill LE, Pouissant-Young T, Cho YJ, Taha H, Mahmoud M, Bowers DC, Margraf L, Tabori U, Hawkins C, Packer RJ, Hill DA, Pomeroy SL, Eberhart CG, Dunn IF, Goumnerova L, Getz G, Chan JA, Santagata S, Hahn WC, Stiles CD, Ligon AH, Kieran MW, Beroukhim R, Ligon KL Proceedings of the National Academy of Sciences of the United States of America 2013 May 110 20 8188-93
An intersection of pediatrics and geriatrics.
Bowers DC Pediatric blood & cancer 2013 Jul
Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review.
Bowers DC, Nathan PC, Constine L, Woodman C, Bhatia S, Keller K, Bashore L The lancet oncology 2013 Jul 14 8 e321-8
Accidental Overdose of Intrathecal Cytarabine in Children (May).
Thienprayoon R, Heym KM, Pelfrey L, Bowers DC The Annals of pharmacotherapy 2013 Apr
Common Pediatric Cerebellar Tumors: Correlation between Cell Densities and Apparent Diffusion Coefficient Metrics.
Koral K, Mathis D, Gimi B, Gargan L, Weprin B, Bowers DC, Margraf L Radiology 2013 Apr
Back pain among long-term survivors of childhood leukemia.
Bowers DC, Griffith T, Gargan L, Cochran CJ, Kleiber B, Foxwell A, Farrow-Gillespie A, Orlino A, Germann JN Journal of pediatric hematology/oncology 2012 Nov 34 8 624-9
Utility of apparent diffusion coefficient ratios in distinguishing common pediatric cerebellar tumors.
Gimi B, Cederberg K, Derinkuyu B, Gargan L, Koral KM, Bowers DC, Koral K Academic radiology 2012 Jul 19 7 794-800
Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.
Koral K, Roy D, Timmons CF, Gargan L, Bowers DC Academic radiology 2012 Jan 19 1 35-9
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
Robertson KA, Nalepa G, Yang FC, Bowers DC, Ho CY, Hutchins GD, Croop JM, Vik TA, Denne SC, Parada LF, Hingtgen CM, Walsh LE, Yu M, Pradhan KR, Edwards-Brown MK, Cohen MD, Fletcher JW, Travers JB, Staser KW, Lee MW, Sherman MR, Davis CJ, Miller LC, Ingram DA, Clapp DW The lancet oncology 2012 Dec 13 12 1218-24
Predictive value of interleukin-5 and monocyte chemotactic protein-1 for bacteremia in children with febrile neutropenia.
Aquino VM, Cost C, Gomez A, Bowers DC, Ramilo O, Ahmad N, Winick N, Leavey PJ Journal of pediatric hematology/oncology 2012 Aug 34 6 e241-5
mTORC1 activation in childhood ependymoma and response to sirolimus.
Bowers DC, Kucejova B, Margraf L, Gargan L, Brugarolas J Journal of neuro-oncology 2011 Jul 103 3 797-801
Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.
Margraf LR, Gargan L, Butt Y, Raghunathan N, Bowers DC Neuro-oncology 2011 Jul 13 7 767-74
Optic nerve tumor in tuberous sclerosis complex is not responsive to sirolimus.
Sparagana SP, Wilkes DC, Thompson CE, Bowers DC Pediatric neurology 2010 Jun 42 6 443-6
Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
Goldsby RE, Liu Q, Nathan PC, Bowers DC, Yeaton-Massey A, Raber SH, Hill D, Armstrong GT, Yasui Y, Zeltzer L, Robison LL, Packer RJ Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Jan 28 2 324-31
Childhood medulloblastoma: current status of biology and treatment.
Klesse LJ, Bowers DC CNS drugs 2010 Apr 24 4 285-301
High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.
Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC, Neglia JP, Meadows AT, Robison LL Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 14 2405-14
Predictors of tumor progression among children with gangliogliomas. Clinical article.
El Khashab M, Gargan L, Margraf L, Koral K, Nejat F, Swift D, Weprin B, Bowers DC Journal of neurosurgery. Pediatrics 2009 Jun 3 6 461-6
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.
Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jan 27 3 385-9
Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors.
Bowers DC, Adhikari S, El-Khashab YM, Gargan L, Oeffinger KC Pediatric blood & cancer 2009 Dec 53 7 1295-301
Intermediate grade meningeal melanocytoma of cervical spine.
El-Khashab M, Koral K, Bowers DC, Johnson-Welch S, Swift D, Nejat F Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2009 Apr 25 4 407-10
Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC, Gargan L, Weprin BE, Mulne AF, Elterman RD, Munoz L, Giller CA, Winick NJ Journal of neurosurgery 2007 Jul 107 1 Suppl 5-10
Rhabdoid tumors in a shared parental environment.
Swinney RM, Bowers DC, Chen TT, Tomlinson GE Pediatric blood & cancer 2006 Sep 47 3 343-4
Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study.
Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, Robison LL, Packer RJ, Oeffinger KC Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Nov 24 33 5277-82
Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study.
Bowers DC, McNeil DE, Liu Y, Yasui Y, Stovall M, Gurney JG, Hudson MM, Donaldson SS, Packer RJ, Mitby PA, Kasper CE, Robison LL, Oeffinger KC Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Sep 23 27 6508-15
Robotically guided radiosurgery for children.
Giller CA, Berger BD, Pistenmaa DA, Sklar F, Weprin B, Shapiro K, Winick N, Mulne AF, Delp JL, Gilio JP, Gall KP, Dicke KA, Swift D, Sacco D, Harris-Henderson K, Bowers D Pediatric blood & cancer 2005 Sep 45 3 304-10
Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma.
Maddrey AM, Bergeron JA, Lombardo ER, McDonald NK, Mulne AF, Barenberg PD, Bowers DC Journal of neuro-oncology 2005 May 72 3 245-53
Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, Stewart C, Krasin MJ, Gajjar A Cancer 2005 Jan 103 1 133-9
Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors.
Bowers DC, Aquino VM, Leavey PJ, Bash RO, Journeycake JM, Tomlinson G, Mulne AF, Haynes HJ, Winick NJ Pediatric blood & cancer 2004 Jan 42 1 93-8
Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization.
Raghavan R, Balani J, Perry A, Margraf L, Vono MB, Cai DX, Wyatt RE, Rushing EJ, Bowers DC, Hynan LS, White CL Journal of neuropathology and experimental neurology 2003 May 62 5 530-7
Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC, Gargan L, Kapur P, Reisch JS, Mulne AF, Shapiro KN, Elterman RD, Winick NJ, Margraf LR Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 Aug 21 15 2968-73
Hepatocyte growth factor activates the Akt pathway and inhibits chemotherapy and radiation induced cell death in human glioma cells
Bowers DC, Fan S, Willimas JA, Rosen EM, Laterra J Cancer Research 2000 60 (15) 4277-4283
Prospective Feasibility and Safety Assessment of Surgical Biopsy for Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma.
Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, Fangusaro J, Goldman S, Tomita T, Alden T, DiPatri A, Rubin JB, Gauvain K, Limbrick D, Leonard J, Geyer JR, Leary S, Browd S, Wang Z, Sood S, Bendel A, Nagib M, Gardner S, Karajannis MA, Harter D, Ayyanar K, Gump W, Bowers DC, Weprin B, MacDonald TJ, Aguilera D, Brahma B, Robison NJ, Kiehna E, Krieger M, Sandler E, Aldana P, Khatib Z, Ragheb J, Bhatia S, Mueller S, Banerjee A, Bredlau AL, Gururangan S, Fuchs H, Cohen KJ, Jallo G, Dorris K, Handler M, Comito M, Dias M, Nazemi K, Baird L, Murray J, Lindeman N, Hornick JL, Malkin H, Sinai C, Greenspan L, Wright KD, Prados M, Bandopadhayay P, Ligon KL, Kieran MW Neuro-oncology 2018 May
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernáiz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schüz J, Johansen C, Andersen TV, Röösli M, Kuehni CE, Grotzer M, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM The Lancet. Oncology 2018 May
Peripheral neuropathy in children and adolescents treated for cancer.
Bjornard KL, Gilchrist LS, Inaba H, Diouf B, Hockenberry MJ, Kadan-Lottick NS, Bowers DC, Dolan ME, Ullrich NJ, Evans WE, Ness KK The Lancet. Child & adolescent health 2018 Oct 2 10 744-754
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z, Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T, Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA The Lancet. Oncology 2018 May
- Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor.
- New therapies for childhood brain tumors
- Evaluation of quality of life and late effects of childhood cancer survivors
- Development of novel chemotherapy regimens for children with recurrent cancer
- Pediatric Brain Tumors